Zymeworks Newsroom

Zymeworks Analyst Ratings

BenzingaNov 22 19:55

HC Wainwright & Co. Reiterates Neutral on Zymeworks, Maintains $12 Price Target

BenzingaNov 22 19:55

Zymeworks Hold Rating: Balancing FDA Milestones With Market Valuation and Future Risks

TipRanksNov 22 19:27

Leerink Partners Maintains Zymeworks(ZYME.US) With Buy Rating, Raises Target Price to $26

Futu NewsNov 22 05:31

Zymeworks Analyst Ratings

BenzingaNov 7 20:15

Leerink Partners Upgrades Zymeworks(ZYME.US) to Buy Rating, Raises Target Price to $25

Futu NewsNov 7 19:31

Zymeworks Is Maintained at Buy by Citigroup

Dow JonesNov 5 01:08

Stifel Maintains Zymeworks(ZYME.US) With Buy Rating, Maintains Target Price $28

Futu NewsNov 1 20:31

HC Wainwright & Co. Reiterates Neutral on Zymeworks, Maintains $12 Price Target

BenzingaNov 1 19:33

Zymeworks Analyst Ratings

BenzingaNov 1 19:24

Zymeworks Analyst Ratings

BenzingaOct 28 21:53

Stifel Maintains Zymeworks(ZYME.US) With Buy Rating, Raises Target Price to $28

Futu NewsOct 28 20:34

Maintaining Neutral: Hold Rating on Zymeworks Amidst Preclinical Progress and Upcoming Catalysts

TipRanksSep 25 18:17

HC Wainwright & Co. Reiterates Neutral on Zymeworks, Maintains $10 Price Target

BenzingaSep 18 19:08

Zymeworks Analyst Ratings

BenzingaSep 18 19:07

Zymeworks' Hold Rating Amidst Promising Data and Competitive HER2+ GEA Treatment Landscape

TipRanksSep 18 18:29

Stifel Maintains Zymeworks(ZYME.US) With Buy Rating, Maintains Target Price $21

Futu NewsSep 10 20:31

Stifel Nicolaus Keeps Their Buy Rating on Zymeworks (ZYME)

TipRanksSep 10 19:40

Buy Rating on Zymeworks Stock Amid Anticipated Zani Approval and Strategic Capital Allocation

TipRanksAug 12 18:44

Analysts Conflicted on These Healthcare Names: Henry Schein (HSIC), Zymeworks (ZYME) and Rocket Pharmaceuticals (RCKT)

TipRanksAug 7 13:34